A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
NCT06138483
·
clinicaltrials.gov ↗
UNKNOWN
Status
267
Enrollment
OTHER
Sponsor class
Conditions
Oropharyngeal Squamous Cell Carcinoma
Sponsor
Centro di Riferimento Oncologico - Aviano